ZAN-23134-40653
4 vaccinations
8 coded responses
16 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 197 / DE
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-22
Dose 2 — Pfizer-BioNTech
-
2021-04-23
Registered in v-safe
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Pain of skin, Tenderness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: skin pain (even hair follicles) - hurts to be touchedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Pain of skin — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Severe skin pain including scalp/haircut follicles, touch hurtMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Pain of skin — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to workFree text: Skin tenderness (moderate)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
-
2021-06-03
Survey response — day 42, dose 2MedDRA: Alopecia, Condition aggravated, Memory impairment, Oxygen saturation decreased, Peripheral swelling, Poor quality sleep, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: It's variable but this week my improved long covid symptoms backslid (oxygen saturation dropping to upper 80s occasionally, feet swelling, hair falling out again, working memory issues) but I had terrible sleep and that tends to cause worse symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-22
Survey response — 3 months, dose 2MedDRA: Alopecia, Arthralgia, COVID-19, Chest pain, Dizziness, Eye swelling, Fatigue, Hypersensitivity, Oxygen saturation decreased, Pre-existing disease — Feeling: Fair · Be unable to work or attend schoolFree text: Flares of long covid symptoms again after the improvement (low oxygen, joint pain, hair loss, light headed, fatigue, hot feeling in lungs, new allergy symptoms (eye swelling), some others I probably forgot), comes and goes a few days at a timeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: Blood pressure increased, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Elevated blood pressure · Healthcare visit (other): Prescription change, increased Candesartan, which REDUCED my long covid symptoms!MedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-25
Dose 3 — ModernaCo-administered: Flu
-
2021-10-25
Call successfulNot applicable - Accidental Reporting
-
2022-04-22
Survey response — 12 months, dose 2MedDRA: Exposure to SARS-CoV-2, SARS-CoV-2 test negative, Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Viral infection possibly covid (testing negative, four other household members all positive)MedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-22
Dose 4 — Other-UnknownCo-administered: Flu
-
2023-04-22
Survey response — 6 months, dose 4MedDRA: Biopsy breast abnormal, Breast hyperplasia, Oxygen saturation decreased, Post-acute COVID-19 syndrome, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-22
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-04-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-10-25 | Moderna | Flu |
| 4 | 2022-10-22 | Other-Unknown | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-21 | Successful 2021-10-25 |
Not applicable - Accidental Reporting |
| 2022-04-22 | Successful 2022-04-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-04-22 | Successful 2023-04-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): skin pain (even hair follicles) - hurts to be touched
Systemic reaction (other): Severe skin pain including scalp/haircut follicles, touch hurt
Systemic reaction (other): Skin tenderness (moderate)
Release 8 — day 42, dose 2
Symptoms: It's variable but this week my improved long covid symptoms backslid (oxygen saturation dropping to upper 80s occasionally, feet swelling, hair falling out again, working memory issues) but I had terrible sleep and that tends to cause worse symptoms cut off by CDC
Release 9 — 3 months, dose 2
Symptoms: Flares of long covid symptoms again after the improvement (low oxygen, joint pain, hair loss, light headed, fatigue, hot feeling in lungs, new allergy symptoms (eye swelling), some others I probably forgot), comes and goes a few days at a time
Release 10 — 6 months, dose 2
Symptoms: Elevated blood pressure
Healthcare visit (other): Prescription change, increased Candesartan, which REDUCED my long covid symptoms!
Release 11 — 12 months, dose 2
Symptoms: Viral infection possibly covid (testing negative, four other household members all positive)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Pre-existing disease | · | · | ✓ |
| SD | Alopecia | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Biopsy breast abnormal | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Breast hyperplasia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Eye swelling | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Memory impairment | ✓ | ✓ | ✓ |
| SD | Oxygen saturation decreased | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Poor quality sleep | ✓ | ✓ | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Pain of skin | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release